KEYNOTE-061: Response to subsequent therapy following second-line pembrolizumab or paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma

Mandala, M.; Yoon, H.; Fuchs, C.; ÖZGÜROĞLU, Mustafa; Bang, Y.; Di Bartolomeo, M.; Ryu, M.; Fornaro, L.; Olesinski, T.; Caglevic, C.; Chung, H.; Muro, K.; Van Cutsem, E.; Elme, A.; Thuss-Patience, P.; Chau, I.; Ohtsu, A.; Wang, A.; Bhagia, P.; Lin, J.; Shih, C.; Shitara, K.

dc.contributor.author	Mandala, M.
dc.contributor.author	Yoon, H.
dc.contributor.author	Fuchs, C.
dc.contributor.author	ÖZGÜROĞLU, Mustafa
dc.contributor.author	Bang, Y.
dc.contributor.author	Di Bartolomeo, M.
dc.contributor.author	Ryu, M.
dc.contributor.author	Fornaro, L.
dc.contributor.author	Olesinski, T.
dc.contributor.author	Caglevic, C.
dc.contributor.author	Chung, H.
dc.contributor.author	Muro, K.
dc.contributor.author	Van Cutsem, E.
dc.contributor.author	Elme, A.
dc.contributor.author	Thuss-Patience, P.
dc.contributor.author	Chau, I.
dc.contributor.author	Ohtsu, A.
dc.contributor.author	Wang, A.
dc.contributor.author	Bhagia, P.
dc.contributor.author	Lin, J.
dc.contributor.author	Shih, C.
dc.contributor.author	Shitara, K.
dc.date.accessioned	2021-03-02T17:41:58Z
dc.date.available	2021-03-02T17:41:58Z
dc.identifier.citation	Yoon H., Fuchs C., ÖZGÜROĞLU M., Bang Y., Di Bartolomeo M., Mandala M., Ryu M., Fornaro L., Olesinski T., Caglevic C., et al., "KEYNOTE-061: Response to subsequent therapy following second-line pembrolizumab or paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma", ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31
dc.identifier.other	vv_1032021
dc.identifier.other	av_4d6a51d4-8c44-48ba-9674-09113c521671
dc.identifier.uri	http://hdl.handle.net/20.500.12627/4291
dc.identifier.uri	https://doi.org/10.1016/j.annonc.2020.04.065
dc.language.iso	eng
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.title	KEYNOTE-061: Response to subsequent therapy following second-line pembrolizumab or paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma
dc.type	Bildiri
dc.contributor.department	Mayo Clinic , ,
dc.identifier.volume	31
dc.contributor.firstauthorID	2284527

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster